AI assistant
Sending…
Beam Therapeutics Inc. — Director's Dealing 2021
Aug 26, 2021
31533_dirs_2021-08-26_5f353838-d26f-4b62-b076-8c044030dc9a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Beam Therapeutics Inc. (BEAM)
CIK: 0001745999
Period of Report: 2021-08-24
Reporting Person: FMR LLC (See Remark 1)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-24 | Common Stock | J | 1615314 | — | Disposed | 4611205 | Indirect |
| 2021-08-24 | Common Stock | J | 16153 | — | Acquired | 16153 | Indirect |
| 2021-08-24 | Common Stock | J | 16153 | — | Disposed | 0 | Indirect |
| 2021-08-24 | Common Stock | J | 1569 | — | Acquired | 2293 | Indirect |
| 2021-08-24 | Common Stock | J | 969189 | — | Acquired | 969342 | Indirect |
| 2021-08-25 | Common Stock | J | 969038 | — | Disposed | 304 | Indirect |
| 2021-08-25 | Common Stock | J | 793736 | — | Acquired | 1744221 | Indirect |
Footnotes
F1: These holdings were acquired or disposed of (as applicable) in the form of a distribution without payment of consideration.
More from Beam Therapeutics Inc.
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Director's Dealing
2026
Feb 26
Annual Report
2026
Feb 24
Regulatory Filings
2026
Feb 24
Regulatory Filings
2026
Feb 12
Major Shareholding Notification
2026
Feb 5
Major Shareholding Notification
2026
Feb 5
Regulatory Filings
2026
Feb 5
Major Shareholding Notification
2026
Feb 3